PZ-128

DB11839InvestigationalSmall molecule

PZ-128 has been used in trials studying the prevention and treatment of Heart Diseases, Coronary Disease, Arteriosclerosis, Vascular Diseases, and Myocardial Ischemia, among others.

Mechanism: Pharmacologically active on Proteinase-activated receptor 1
Curator reviewed
Formula / weight: C₅₅H₉₉N₁₃O₉ · 1086.479 g/mol (avg)
Code names: PZ-128

Resolves to

Compound

UNIIIYT6MP4NS9CAS371131-16-7PubChem72187679

Structure

InChIKeyVZRIKWNVDCTBTF-BKGFHLQYSA-NSMILES

CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O

Targets

P25116F2R

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with PZ-128, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account